Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group

Author:

Karschnia Philipp12ORCID,Dietrich Jorg3,Bruno Francesco4ORCID,Dono Antonio5ORCID,Juenger Stephanie T6,Teske Nico12,Young Jacob S7,Sciortino Tommaso8,Häni Levin9,van den Bent Martin10,Weller Michael11ORCID,Vogelbaum Michael A12,Morshed Ramin A7,Haddad Alexander F7,Molinaro Annette M7ORCID,Tandon Nitin5ORCID,Beck Juergen9,Schnell Oliver9,Bello Lorenzo8,Hervey-Jumper Shawn7,Thon Niklas12,Grau Stefan J6,Esquenazi Yoshua5ORCID,Rudà Roberta4,Chang Susan M7,Berger Mitchel S7ORCID,Cahill Daniel P13ORCID,Tonn Joerg-Christian12ORCID

Affiliation:

1. Department of Neurosurgery, LMU University Hospital of the Ludwig-Maximilians-University Munich , Munich , Germany

2. German Cancer Consortium (DKTK) , Partner Site Munich , Germany

3. Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, MA , USA

4. Division of Neuro-Oncology, Department of Neuroscience, University of Turin , Italy

5. Department of Neurosurgery, McGovern Medical School at UT Health Houston , Houston, TX , USA

6. Department of Neurosurgery, University of Cologne , Cologne , Germany

7. Department of Neurosurgery and Division of Neuro-Oncology, University of San Francisco , San Francisco, CA , USA

8. Division of Neuro-Oncology, Department of Oncology and Hemato-Oncology, University of Milan , Milan , Italy

9. Department of Neurosurgery, Medical Center – University of Freiburg , Freiburg , Germany

10. Department of Neurology, Erasmus MC Cancer Institute , Rotterdam , The Netherlands

11. Department of Neurology, University Hospital and University of Zurich , Zurich , Switzerland

12. Department of NeuroOncology, Moffitt Cancer Center , Tampa, FL , USA

13. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA

Abstract

Abstract Background Resection of the contrast-enhancing (CE) tumor represents the standard of care in newly diagnosed glioblastoma. However, some tumors ultimately diagnosed as glioblastoma lack contrast enhancement and have a ‘low-grade appearance’ on imaging (non-CE glioblastoma). We aimed to (a) volumetrically define the value of non-CE tumor resection in the absence of contrast enhancement, and to (b) delineate outcome differences between glioblastoma patients with and without contrast enhancement. Methods The RANO resect group retrospectively compiled a global, eight-center cohort of patients with newly diagnosed glioblastoma per WHO 2021 classification. The associations between postoperative tumor volumes and outcome were analyzed. Propensity score-matched analyses were constructed to compare glioblastomas with and without contrast enhancement. Results Among 1323 newly diagnosed IDH-wildtype glioblastomas, we identified 98 patients (7.4%) without contrast enhancement. In such patients, smaller postoperative tumor volumes were associated with more favorable outcome. There was an exponential increase in risk for death with larger residual non-CE tumor. Accordingly, extensive resection was associated with improved survival compared to lesion biopsy. These findings were retained on a multivariable analysis adjusting for demographic and clinical markers. Compared to CE glioblastoma, patients with non-CE glioblastoma had a more favorable clinical profile and superior outcome as confirmed in propensity score analyses by matching the patients with non-CE glioblastoma to patients with CE glioblastoma using a large set of clinical variables. Conclusions The absence of contrast enhancement characterizes a less aggressive clinical phenotype of IDH-wildtype glioblastomas. Maximal resection of non-CE tumors has prognostic implications and translates into favorable outcome.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3